Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $119,231.31 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 2,049 shares of the company’s stock in a transaction on Tuesday, December 24th. The stock was sold at an average price of $58.19, for a total transaction of $119,231.31. Following the completion of the transaction, the chief financial officer now owns 22,615 shares of the company’s stock, valued at $1,315,966.85. This trade represents a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Kewaunee Scientific Stock Up 0.3 %

Shares of NASDAQ KEQU opened at $63.81 on Friday. The stock has a market capitalization of $183.13 million, a P/E ratio of 10.11 and a beta of 0.80. Kewaunee Scientific Co. has a one year low of $27.00 and a one year high of $66.15. The firm’s 50 day simple moving average is $42.62 and its two-hundred day simple moving average is $43.29. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

Hedge Funds Weigh In On Kewaunee Scientific

Several institutional investors and hedge funds have recently made changes to their positions in KEQU. JPMorgan Chase & Co. lifted its stake in Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares during the last quarter. Barclays PLC purchased a new position in shares of Kewaunee Scientific in the third quarter worth about $121,000. Geode Capital Management LLC lifted its stake in shares of Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after acquiring an additional 1,941 shares during the last quarter. State Street Corp purchased a new stake in Kewaunee Scientific during the 3rd quarter valued at about $266,000. Finally, De Lisle Partners LLP grew its position in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares during the last quarter. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.